CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mersana Therapeutics Inc Company Snapshot
Mersana Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mersana Therapeutics Inc with three other companies in this sector in UNITED STATES : Intellia Therapeutics Inc (2019 sales of $43.10 million of which 100% was genome editing-based therapies), Applied Genetic Technologies Corp ($41.69 million of which 100% was Gene therapy), and Arvinas Inc ($42.98 million of which 100% was Biopharmaceutical).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mersana Therapeutics Inc
  Stock Performance Chart for Mersana Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 17.88
(Figures in U.S. Dollars)
1 Week -8.2%   13 Weeks -18.9%  
4 Weeks -20.8%   52 Weeks 983.6%  
 
Mersana Therapeutics Inc Key Data:
  Ticker: MRSN Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 42,123,000
(Year Ending Jan 2020).
Employees: 83
  Currency: U.S. Dollars Market Cap: 1,222,656,035
  Fiscal Yr Ends: December Shares Outstanding: 68,381,210
  Share Type: Common Closely Held Shares: 1,552,105
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.